Published in
Oxford University Press, Journal of the National Cancer Institute, 8(108), p. djw111, 2016
DOI: 10.1093/jnci/djw111
Links
Tools
RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Journal article published in 2016 by
Sinead Toomey,
Alex J. Eustace,
Laura B. Pritzker,
Ken P. H. Pritzker,
Joanna Fay,
Anthony O’Grady,
Robert Cummins,
Liam Grogan,
John Kennedy,
Darran O’Connor 
,
Leonie Young,
Elaine W. Kay,
Norma O’Donovan,
William M. Gallagher,
Roshni Kalachand
and other authors.
,
Leonie Young,
Elaine W. Kay,
Norma O’Donovan,
William M. Gallagher,
Roshni Kalachand
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 